文献速递免疫规划

流感疫苗接种与实验性人鼻咽肺炎球菌定植相关症状

Symptoms associated with influenza vaccination and experimental human pneumococcal colonisation of the nasopharynx.
PubMed 文献 · Vaccine · 2020-02-05

该随机盲法实验比较了减毒活流感疫苗(LAIV)与四价灭活流感疫苗(TIV)在细菌接种前后不同时序下,健康成人鼻咽部肺炎球菌定植相关症状。结果显示,疫苗时序和定植状态显著影响症状报告:当流感疫苗先于细菌接种时,LAIV组鼻部症状少于TIV组(OR 0.57,p<0.01),且定植状态仅影响TIV组症状。

要点

  • 流感疫苗与细菌接种的时序影响鼻咽部定植相关症状报告
  • 疫苗先行时LAIV组鼻部症状少于TIV组(OR 0.57,p<0.01)
  • TIV先行时定植者症状多于非定植者(52.17% vs 34.21%,p<0.05)

核心结论

  • 鼻咽部活病毒疫苗与细菌共感染期间的症状直接受病原体获得先后顺序影响。
  • 鼻部肺炎球菌定植仅在TIV先于细菌暴露时直接影响症状。

研究设计与样本

  • 随机、盲法给予减毒活流感疫苗(LAIV)或四价灭活流感疫苗(TIV),或先于细菌接种或后于细菌接种,间隔3天。
  • 通过鼻洗液确定肺炎球菌的存在和密度,参与者在首次干预至第二次干预后6天完成症状问卷。

主要发现

  • 流感疫苗接种先于细菌接种的研究中:LAIV组鼻部症状少于TIV组(OR 0.57,p<0.01)。
  • 流感疫苗接种先于细菌接种的研究中:定植状态仅影响TIV组,接种后定植者报告症状多于非定植者(n=12/23 [52.17%] vs n=13/38 [34.21%],p<0.05)。
  • 流感疫苗接种后于细菌接种的研究中:接种后及后续疫苗接种后LAIV组与TIV组症状报告无差异,且症状不受定植状态影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Nasopharyngeal colonisation by S. pneumoniae is a prerequisite for invasive pneumococcal infections. Influenza co-infection leads to increased susceptibility to secondary pneumonia and mortality during influenza epidemics. Increased bacterial load and impaired immune responses to pneumococcus caused by influenza play a role in this increased susceptibility. Using an Experimental Human Challenge Model and influenza vaccines, we examined symptoms experienced by healthy adults during nasal co-infection with S. pneumoniae and live attenuated influenza virus. METHODS: Randomised, blinded administration of Live Attenuated Influenza Vaccine (LAIV) or Tetravalent Inactivated Influenza Vaccine (TIV) either preceded bacterial inoculation or followed it, separated by a 3-day interval. The presence and density of S. pneumoniae was determined from nasal washes. Participants completed a symptom questionnaire from the first intervention until 6 days post second intervention. RESULTS: The timing and type of influenza vaccination and presence of S. pneumoniae in the nasopharynx significantly affected symptom reporting. In the study where influenza vaccination preceded bacterial inoculation: nasal symptoms were less common in the LAIV group than the TIV group (OR 0.57, p < 0.01); with colonisation status only affecting the TIV group where more symptoms were reported by colonised participants compared to non-colonised participants following inoculation (n = 12/23 [52.17%] vs n = 13/38 [34.21%], respectively; p < 0.05). In the study where influenza vaccination followed bacterial inoculation: no difference was seen in the symptoms reported between the LAIV and TIV groups following inoculation and subsequent vaccination; and symptoms were unaffected by colonisation status. CONCLUSION: Symptoms experienced during live viral vaccination and bacterial co-infection in the nasopharynx are directly affected by the precedence of the pathogen acquisition. Symptoms were directly affected by nasal pneumococcal colonisation but only when TIV was given prior to bacterial exposure.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Hales C, Jochems SP, Robinson R, et al. Symptoms associated with influenza vaccination and experimental human pneumococcal colonisation of the nasopharynx. Vaccine. 2020. PMID: 32035708. doi:10.1016/j.vaccine.2020.01.070

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。